INSM FY 2024 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$364M+19.2% YoY

Gross Profit

$278M76.4% margin

Operating Income

-$878M-241.5% margin

Net Income

-$914M-251.2% margin

EPS (Diluted)

$-5.57

Cash Flow

Operating Cash Flow

-$684M

Free Cash Flow

-$706M

Stock-Based Comp.

$97M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.7B

Stockholders' Equity

$285M

Cash & Equivalents

$555M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$364M	$305M	+19.2%
Gross Profit	$278M	$240M	+16.0%
Operating Income	-$878M	-$710M	-23.8%
Net Income	-$914M	-$750M	-21.9%